Related Articles
Gene therapy for gliomas: p53 and E2F-1 proteins and the target of apoptosis.
Distinct promoter usage of mdm2 gene in human breast cancer
Differential activation of the Fas/CD95 pathway by Ad-p53 in human gliomas
Prognostic value of simultaneous expression of p21 and mdm2 in breast carcinomas treated by adjuvant chemotherapy with antracyclin.
Phosphorylation of mdm2 at serine 269 impairs its interaction with the retinoblastoma protein